Bottom line
ERGMX vs GJRTX: the short answer
ERGMX (Eaton Vance Global Macro Absolute Return Fund) and GJRTX (Goldman Sachs Absolute Return Tracker Fund) are both mutual funds.
But GJRTX is far broader, holding 3,239 positions to 1 for ERGMX, so beyond the top names it adds exposure ERGMX doesn't have.
GJRTX is cheaper at 0.74% vs 1.76% — a difference of $102 a year per $10,000 invested.
Over five years, GJRTX returned +5.4% a year vs +5.3% for ERGMX.
Updated Nov 19, 2026
ERGMX vs GJRTX side by side
| ERGMX | GJRTX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Morgan Stanley | Goldman Sachs |
| Category | Alternatives | Alternatives |
| Expense ratio | 1.76% | 0.74% |
| Annual cost per $10k | $176 | $74 |
| 10-yr cost on $10k (prospectus) | $2,073 | $984 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +11.9% | +9.7% |
| 5-yr return (annualized) | +5.3% | +5.4% |
| 10-yr return (annualized) | +4.2% | +5.1% |
| Best quarter | — | +6.6% |
| Worst quarter | — | −9.8% |
| Net assets (fund) | $4.2B | $6.2B |
| Number of holdings | 1 | 3,239 |
| Portfolio turnover | 142% | 134% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
ERGMX and GJRTX share none of their top holdings.
ERGMX top 10
- Global Macro Portfolio — 100.02%
GJRTX top 10
- Goldman Sachs Central Government Fund — 9.70%
- iShares Core MSCI Emerging Markets ETF — 5.59%
- State Street SPDR Portfolio Emerging Markets ETF — 5.57%
- Vanguard Short-Term Inflation-Protected Securities ETF — 5.07%
- Goldman Sachs Financial Square Government Fund — 3.48%
- NVIDIA Corp — 3.20%
- Apple Inc — 3.04%
- State Street Technology Select Sector SPDR ETF — 2.95%
- Microsoft Corp — 2.06%
- State Street Industrial Select Sector SPDR ETF — 1.77%
FAQ
What is the difference between ERGMX and GJRTX?
Which is cheaper, ERGMX or GJRTX?
Should I own both ERGMX and GJRTX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.